Methods to identify drug deposition in the lungs following inhalation (Q34229278)

31 July 2017

1 reference

title

Methods to identify drug deposition in the lungs following inhalation (English)

1 reference

31 July 2017

H Chrystyn

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

British Journal of Clinical Pharmacology

31 July 2017

published in

1 reference

31 July 2017

volume

51

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

289-299

1 reference

The pathology of asthma, with special reference to changes in the bronchial mucosa

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Assessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, U.K. on 17 April 1998.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Regulatory aspects of modifications to innovator bronchodilator metered dose inhalers and development of generic substitutes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Effects of airway calibre on lung delivery of nebulised salbutamol

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Relative bioavailability of salbutamol to the lung following inhalation via a novel dry powder inhaler and a standard metered dose inhaler

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Optimal particle size for beta 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Lung bioavailability of generic and innovator salbutamol metered dose inhalers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Lung bioavailability of generic and innovator salbutamol MDIs

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Volumatic usage: some generic salbutamol metered dose inhalers can be used

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Beta-adrenergic receptors and their regulation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Deposition of pressurised aerosols in the human respiratory tract

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

The importance of particle size in response to inhaled bronchodilators

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Evaluation of jet nebulisers for use with gentamicin solution

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Droplet size distributions of nebulised aerosols for inhalation therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Autoradiographic visualization of beta-adrenoceptor subtypes in human lung

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Pressurised aerosol deposition in the human lung with and without an "open" spacer device

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Localization of β2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Determination of the relative bioavailability of salbutamol to the lung following inhalation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Comparison of the extrapulmonary beta2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose-inhaler and modified actuator device

28 July 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01304.X

Pharmacokinetics and pharmacodynamics of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01304.X

Absorption of drugs by the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01304.X

Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01304.X

Improvement of pressurised aerosol deposition with Nebuhaler spacer device

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01304.X

Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01304.X

Assessment of deposition of inhaled aerosol in the respiratory tract of man using three-dimensional multimodality imaging and mathematical modeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01304.X

Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

Efficient drug delivery to the lungs from a continuously operated open-vent nebulizer and low pressure compressor system.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014454

The optimal particle size for β-adrenergic aerosols in mild asthmatics

28 October 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01304.X

Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01304.X

Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration

21 January 2018

1 reference

12 December 2020

The inhalation device influences lung deposition and bronchodilating effect of terbutaline

1 reference

12 December 2020

The pulmonary deposition of two aerosol preparations of nedocromil sodium delivered by MDI assessed by single photon emission computed tomography

1 reference

12 December 2020

Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol

1 reference

12 December 2020

Evaluation of plasma and urinary salbutamol levels in COPD

1 reference

12 December 2020

Determination of the relative bioavailability of nedocromil sodium to the lung following inhalation using urinary excretion

1 reference

12 December 2020

Improved delivery of inhaled steroids to the large and small airways

1 reference

12 December 2020

Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics

1 reference

12 December 2020

Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose

1 reference

12 December 2020

Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma

1 reference

12 December 2020

Adrenal effects and pharmacokinetics of CFC-free beclomethasone dipropionate: a 14-day dose-response study

1 reference

12 December 2020

Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma

1 reference

12 December 2020

Bronchodilator delivery from Gentlehaler, a new low-velocity pressurized aerosol inhaler

1 reference

12 December 2020

Lung deposition from four nebulizers

1 reference

12 December 2020

The relative bioavailability of salbutamol to the lung using urinary excretion following inhalation from a novel dry powder inhaler: the effect of inhalation rate and formulation

1 reference

12 December 2020

Deposition of pressurized suspension aerosols inhaled through extension devices

1 reference

12 December 2020

Effects of various inhalation modes on the deposition of radioactive pressurized aerosols

1 reference

12 December 2020

Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid

1 reference

12 December 2020

Effect of InspirEase on the deposition of metered-dose aerosols in the human respiratory tract

1 reference

12 December 2020

New method for easy labeling of beta-2-agonists in the metered dose inhaler with technetium 99m

1 reference

12 December 2020

Comparisons of planar and tomographic gamma scintigraphy to measure the penetration index of inhaled aerosols

1 reference

12 December 2020

Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition

1 reference

12 December 2020

A method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline

1 reference

12 December 2020

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

1 reference

12 December 2020

Dry powder inhalers are bioequivalent to metered-dose inhalers. A study using a new urinary albuterol (salbutamol) assay technique

1 reference

12 December 2020

Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler

1 reference

12 December 2020

Alveolar tissue inflammation in asthma

1 reference

12 December 2020

The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics

1 reference

12 December 2020

Lung immunopathology in cases of sudden asthma death

1 reference

12 December 2020

Development and validation of an ion-pair liquid chromatographic method for the quantitation of sodium cromoglycate in urine following inhalation

1 reference

12 December 2020

Comparative lung delivery of salbutamol given via Turbuhaler and Diskus dry powder inhaler devices

1 reference

12 December 2020

Is total particle dose more important than particle distribution?

1 reference

12 December 2020

Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate

1 reference

12 December 2020

Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines: comparison of RESPIMAT with conventional metered-dose inhalers with and without spacer devices

1 reference

12 December 2020

Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices

1 reference

12 December 2020

10.1046/J.1365-2125.2001.01304.X

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference